Indian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...

India and the US are pushing for an interim trade pact, with high-level talks led by Piyush Goyal and Jamieson Greer aiming for a deal befo...

Niti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...

India's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...

India and the US are in high-level talks to finalize the first phase of their bilateral trade agreement. Commerce Minister Piyush Goyal met...

Goyal said he would be "happy" if a deal is finalised before July 24, when Washington's temporary 10% tariff on trading partners is due to ...

India's trade minister, Piyush Goyal, revealed on Monday that a trade agreement with the United States is experiencing delays. The primary ...

The U.S. military conducted another strike on a suspected drug boat in the eastern Pacific, resulting in two deaths and six survivors. This...

U.S. Trade Representative Jamieson Greer has arrived in New Delhi to finalise an interim trade agreement with India. This visit is the culm...

India's merchandise exports saw a robust 15% year-on-year growth in April-June, defying global economic headwinds, according to Commerce Mi...

In a significant development, India and the US are set to conclude the first phase of their trade agreement this week. Commerce Minister Pi...

The US has launched a trade probe into Germany's pharmaceutical pricing, alleging it unfairly burdens American commerce and forces the US t...

Pfizer's finance chief Dave Denton is leaving on August 15. Cecile Guegan will be the interim chief financial officer. Denton's departure r...

Global economic shocks from trade disruptions and geopolitical tensions are reshaping resilience, according to Raghuram Rajan. He stresses ...

Indian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...

Indian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...

Global drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...